Complex drug use patterns and associated HIV transmission risk behaviors in an Internet sample of U.S. men who have sex with men.

Gary Yu, Melanie M Wall, Mary Ann Chiasson, Sabina Hirshfield
Author Information
  1. Gary Yu: Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA.

Abstract

Although the relationship between drug use and HIV risk among men who have sex with men (MSM) is well described, relatively few studies have employed empirical methods to assess underlying classes of drug use that may better predict the risk of HIV or sexually transmitted infections (STIs) among MSM. The aim of this study was to determine whether latent class analysis (LCA) would identify underlying drug classes reported prior to sex, as well as predict unprotected anal intercourse (UAI) in the last sexual encounter among MSM. From 2004 to 2005, an anonymous online survey was conducted among 8,717 sexually active MSM recruited from gay-affiliated U.S. websites. LCA clustered participants into six distinct drug use classes based on the specific types and number of drugs used: (1) low/no drug use, (2) recreational drug use, (3) poppers with prescription erectile dysfunction (ED) drug use, (4) poppers with both prescription and non-prescription ED drug use, (5) recreational, club, and ED drug use, and (6) high polydrug use. Compared with men in Class 1, men in the highest drug use class were 4.84 times more likely to report UAI in their last sexual encounter and 3.78 times more likely to report an STI in the past year (both ps < .001). Younger MSM aged 18-29 were significantly more likely to report an STI than men aged 50 and above (p < .001). There is a need to better understand the complex relationship between a diverse set of drugs used among MSM and how polydrug use impacts sexual negotiation over time.

References

  1. J Sex Med. 2010 Sep;7(9):3104-14 [PMID: 19968773]
  2. Arch Sex Behav. 2009 Aug;38(4):583-90 [PMID: 18185990]
  3. J Sex Med. 2008 Dec;5(12):2766-79 [PMID: 18547383]
  4. J Urban Health. 2005 Mar;82(1 Suppl 1):i62-70 [PMID: 15738319]
  5. Annu Rev Psychol. 2004;55:803-32 [PMID: 14744235]
  6. Arch Sex Behav. 2011 Apr;40(2):273-9 [PMID: 19330436]
  7. PLoS One. 2012;7(10):e46252 [PMID: 23071551]
  8. Arch Sex Behav. 2013 Feb;42(2):291-302 [PMID: 22012413]
  9. J Med Internet Res. 2004 Nov 29;6(4):e41 [PMID: 15631965]
  10. AIDS Behav. 2012 Apr;16(3):491-8 [PMID: 22327371]
  11. AIDS Behav. 2013 Mar;17(3):926-30 [PMID: 21769494]
  12. J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):235-43 [PMID: 17179769]
  13. AIDS Behav. 2014 Jul;18(7):1339-51 [PMID: 24065437]
  14. AIDS Patient Care STDS. 2012 Jan;26(1):36-52 [PMID: 22070609]
  15. Am J Public Health. 2002 Feb;92(2):294-7 [PMID: 11818309]
  16. AIDS Care. 2009 Sep;21(9):1081-9 [PMID: 20024766]
  17. Sex Health. 2009 Dec;6(4):310-7 [PMID: 19917200]
  18. J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):421-6 [PMID: 15097159]
  19. AIDS Behav. 2009 Dec;13(6):1084-96 [PMID: 18498049]
  20. Am J Infect Dis. 2006;2(2):107-114 [PMID: 17191089]
  21. J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):176-82 [PMID: 21119524]
  22. Epidemiology. 2005 Sep;16(5):701-4 [PMID: 16135951]
  23. AIDS Behav. 2012 Aug;16(6):1394-410 [PMID: 22323004]
  24. Addiction. 2004 Jul;99(7):885-96 [PMID: 15200584]
  25. Subst Use Misuse. 2006;41(10-12):1551-601 [PMID: 17002993]
  26. AIDS Patient Care STDS. 2009 Dec;23(12):1017-23 [PMID: 19909171]
  27. J Sex Med. 2009 Aug;6(8):2311-20 [PMID: 19493293]
  28. J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):349-55 [PMID: 19387357]
  29. AIDS Educ Prev. 2002 Dec;14(6):482-95 [PMID: 12512849]
  30. AIDS Behav. 2011 Oct;15(7):1561-9 [PMID: 21607643]
  31. J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):344-50 [PMID: 16980913]
  32. J HIV Ther. 2007 Jun;12(2):44-8 [PMID: 17641572]
  33. Sex Transm Dis. 2007 Aug;34(8):586-91 [PMID: 17334264]
  34. Sex Transm Infect. 2008 Nov;84(6):509-11 [PMID: 19028957]
  35. Stat Med. 1986 Jan-Feb;5(1):21-7 [PMID: 3961312]

Grants

  1. R01 HL111195/NHLBI NIH HHS
  2. T32 DA007233/NIDA NIH HHS
  3. P30 DA011041/NIDA NIH HHS
  4. R01 AA014924/NIAAA NIH HHS
  5. 5T32 DA007233/NIDA NIH HHS

MeSH Term

Adolescent
Adult
HIV Infections
Homosexuality, Male
Humans
Illicit Drugs
Internet
Interviews as Topic
Male
Middle Aged
Qualitative Research
Risk-Taking
Sexually Transmitted Diseases
Substance-Related Disorders
United States
Unsafe Sex
Young Adult

Chemicals

Illicit Drugs

Word Cloud

Created with Highcharts 10.0.0usedrugmenMSMamongHIVrisksexclassessexualEDlikelyreportrelationshipwellunderlyingbetterpredictsexuallyclassLCAUAIlastencounterUSdrugs1recreational3poppersprescription4polydrugtimesSTI001agedAlthoughdescribedrelativelystudiesemployedempiricalmethodsassessmaytransmittedinfectionsSTIsaimstudydeterminewhetherlatentanalysisidentifyreportedpriorunprotectedanalintercourse20042005anonymousonlinesurveyconducted8717activerecruitedgay-affiliatedwebsitesclusteredparticipantssixdistinctbasedspecifictypesnumberused:low/no2erectiledysfunctionnon-prescription5club6highComparedClasshighest8478pastyearps <Younger18-29significantly50p <needunderstandcomplexdiversesetusedimpactsnegotiationtimeComplexpatternsassociatedtransmissionbehaviorsInternetsample

Similar Articles

Cited By (35)